Published in Curr Opin Immunol on August 01, 1996
Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect Immun (1998) 2.56
An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med (2002) 2.25
Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol (1999) 1.93
Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun (1999) 1.91
Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev (2004) 1.87
Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun (2004) 1.82
Both decorin-binding proteins A and B are critical for the overall virulence of Borrelia burgdorferi. Infect Immun (2008) 1.67
Interleukin-12 in infectious diseases. Clin Microbiol Rev (1997) 1.63
Therapeutic passive vaccination against chronic Lyme disease in mice. Proc Natl Acad Sci U S A (1997) 1.50
PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period. J Clin Microbiol (2000) 1.35
Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol (2004) 1.29
Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect Immun (2003) 1.10
Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl. J Bacteriol (2000) 1.02
Characterization of unique regions of Borrelia burgdorferi surface-located membrane protein 1. Infect Immun (2010) 1.00
Increasing the interaction of Borrelia burgdorferi with decorin significantly reduces the 50 percent infectious dose and severely impairs dissemination. Infect Immun (2007) 0.99
Common and unique contributions of decorin-binding proteins A and B to the overall virulence of Borrelia burgdorferi. PLoS One (2008) 0.99
Dissociation of infectivity and pathogenicity in Borrelia burgdorferi. Infect Immun (2001) 0.99
Mycosis fungoides: is it a Borrelia burgdorferi-associated disease? Br J Cancer (2006) 0.98
Ablation of interleukin-12 exacerbates Lyme arthritis in SCID mice. Infect Immun (1997) 0.98
Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients. Infect Immun (2001) 0.95
The failure of immune response evasion by linear plasmid 28-1-deficient Borrelia burgdorferi is attributable to persistent expression of an outer surface protein. Infect Immun (2008) 0.93
Verification and dissection of the ospC operator by using flaB promoter as a reporter in Borrelia burgdorferi. Microb Pathog (2008) 0.91
Lack of humoral immune protection against Treponema denticola virulence in a murine model. Infect Immun (1999) 0.86
Protein-losing nephropathy associated with Borrelia burgdorferi seropositivity in a soft-coated wheaten terrier: response to therapy. Can Vet J (2013) 0.77
Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques (1998) 11.39
Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol (2000) 6.68
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A (1984) 6.62
Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol (1999) 3.80
Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun (2001) 3.55
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun (1994) 2.81
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci U S A (1984) 2.71
Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol (1999) 2.39
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun (1993) 2.18
Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect Immun (1991) 2.13
Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun (1998) 2.12
A complement receptor locus: genes encoding C3b/C4b receptor and C3d/Epstein-Barr virus receptor map to 1q32. J Immunol (1987) 1.94
Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun (1999) 1.91
Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect Immun (1992) 1.71
Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun (1994) 1.66
Resistance to Lyme disease in decorin-deficient mice. J Clin Invest (2001) 1.46
Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement. Proc Natl Acad Sci U S A (1986) 1.42
Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect Immun (1994) 1.40
Saliva of the tick Ixodes dammini inhibits neutrophil function. Exp Parasitol (1990) 1.38
The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol (1998) 1.38
Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors. J Immunol (1985) 1.37
Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun (2006) 1.35
Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect Immun (1992) 1.33
Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils. J Immunol (1997) 1.31
Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr Opin Microbiol (2001) 1.31
Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kappa B and inflammatory activation in human endothelial cells. J Immunol (1996) 1.30
The identification of N-linked oligosaccharides on the human CR2/Epstein-Barr virus receptor and their function in receptor metabolism, plasma membrane expression, and ligand binding. J Biol Chem (1985) 1.29
Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun (2001) 1.17
Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect Immun (1995) 1.11
Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities. J Immunol Methods (1986) 0.93
The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation. J Clin Immunol (1986) 0.92
Polymerase chain reaction detection of Lyme disease: correlation with clinical manifestations and serologic responses. Am J Clin Pathol (1996) 0.91
Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles. J Immunol (1989) 0.89
Loss of human CR1- and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations. J Immunol (1990) 0.89
Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry. J Immunol (1989) 0.88
Structure and thermodynamics of a two-dimensional Coulomb fluid in the strong association regime. J Chem Phys (2007) 0.88
Microphthalmic mice display a B cell deficiency similar to that seen for mast and NK cells. J Immunol (1999) 0.87
Defining a transcriptional fingerprint of murine splenic B-cell development. Genes Immun (2008) 0.86
Expression of the murine CD21 gene is regulated by promoter and intronic sequences. J Immunol (1997) 0.86
Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes. Infect Immun (2000) 0.85
Functional characterization of Pactolus, a beta-integrin-like protein preferentially expressed by neutrophils. J Biol Chem (2001) 0.84
Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation. J Immunol (1999) 0.83
Overexpression of RANKL implicates IFN-beta-mediated elimination of B-cell precursors in the osteopetrotic bone of microphthalmic mice. J Bone Miner Res (2003) 0.81
CD28 expression by mouse mast cells is modulated by lipopolysaccharide and outer surface protein A lipoprotein from Borrelia burgdorferi. J Immunol (1997) 0.81
Identification of pactolus, an integrin beta subunit-like cell-surface protein preferentially expressed by cells of the bone marrow. J Biol Chem (1998) 0.80
Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21). Prog Clin Biol Res (1989) 0.80
Identification of 5'-regions affecting the expression of the human CR2 gene. J Immunol (1991) 0.79
Cell-specific expression of the murine CD21 gene depends on accessibility of promoter and intronic elements. J Immunol (2000) 0.78
Genomic organization, chromosomal localization, and transcriptional variants of the murine Pactolus gene. Mamm Genome (1999) 0.78
E and P selectins are not required for resistance to severe murine lyme arthritis. Infect Immun (1998) 0.77
Fetal outcome in murine Lyme disease. Infect Immun (1995) 0.76
Quasi-two-dimensional dipolar fluid at low densities: Monte Carlo simulations and theory. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 0.75
Phase transition in two-dimensional dipolar fluids at low densities. Phys Rev E Stat Nonlin Soft Matter Phys (2006) 0.75
Dielectric constant of atomic fluids with variable polarizability. Proc Natl Acad Sci U S A (1980) 0.75
Adsorption of a diatomic molecular fluid into random porous media. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 0.75
Phase diagram of a symmetric binary fluid in a porous matrix. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 0.75
Monte Carlo approach to the gas-liquid transition in porous materials. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 0.75